Growth Metrics

Evolus (EOLS) Liabilities and Shareholders Equity (2018 - 2025)

Evolus (EOLS) has disclosed Liabilities and Shareholders Equity for 8 consecutive years, with $225.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Liabilities and Shareholders Equity fell 2.88% year-over-year to $225.9 million, compared with a TTM value of $887.0 million through Dec 2025, down 3.81%, and an annual FY2025 reading of $225.9 million, down 2.88% over the prior year.
  • Liabilities and Shareholders Equity was $225.9 million for Q4 2025 at Evolus, up from $219.0 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $257.5 million in Q4 2021 and bottomed at $157.2 million in Q1 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $208.4 million, with a median of $217.1 million recorded in 2021.
  • The sharpest move saw Liabilities and Shareholders Equity crashed 30.88% in 2022, then soared 41.15% in 2024.
  • Year by year, Liabilities and Shareholders Equity stood at $257.5 million in 2021, then plummeted by 30.88% to $178.0 million in 2022, then increased by 6.19% to $189.0 million in 2023, then rose by 23.05% to $232.6 million in 2024, then dropped by 2.88% to $225.9 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for EOLS at $225.9 million in Q4 2025, $219.0 million in Q3 2025, and $228.8 million in Q2 2025.